A rating of 36 puts Kinnate Biopharma Inc (KNTE) near the middle of the Biotechnology industry according to InvestorsObserver. Kinnate Biopharma Inc's score of 36 means it scores higher than 36% of stocks in the industry. Kinnate Biopharma Inc also received an overall rating of 38, putting it above 38% of all stocks. Biotechnology is ranked 49 out of the 148 industries.
KNTE has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on KNTE!